Recurrent Follicular Helper T-Cell Lymphoma, Angioimmunoblastic-Type: Clinical Trials

2 trials for Recurrent Follicular Helper T-Cell Lymphoma, Angioimmunoblastic-Type, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 not yet recruiting. 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 12Active not recruiting 1, Not yet recruiting 1

Follow Recurrent Follicular Helper T-Cell Lymphoma, Angioimmunoblastic-Type: new trials by email Literature Review of Recurrent Follicular Helper T-Cell Lymphoma, Angioimmunoblastic-Type trials Research Report on Recurrent Follicular Helper T-Cell Lymphoma, Angioimmunoblastic-Type

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Belinostat in Combination With Azacitidine or Pralatrexate for the Treatment of Relapse or Refractory T-cell Lymphoma
Azacitidine, Belinostat, Biospecimen Collection - Recurrent Anaplastic Large Cell Lymphoma, Recurrent Enteropathy-Associated T-Cell Lymphoma
Phase 1Not yet recruitingCity of Hope Medical Center402027-01-032026-07-09
Anti-ICOS Monoclonal Antibody MEDI-570 in Treating Patients With Relapsed or Refractory Peripheral T-cell Lymphoma Follicular Variant or Angioimmunoblastic T-cell Lymphoma
Anti-ICOS Monoclonal Antibody MEDI-570, Laboratory Biomarker Analysis, Pharmacological Study - Advanced Primary Cutaneous T-Cell Non-Hodgkin Lymphoma, Recurrent Follicular Helper T-Cell Lymphoma, Angioimmunoblastic-Type
Phase 1Active not recruitingNational Cancer Institute (NCI)212016-09-132026-10-26

Narrower conditions

Lymphoma, T-Cell (2)  ·  Enteropathy-Associated T-Cell Lymphoma (1)  ·  Lymphoma, Follicular (1)  ·  Lymphoma, Large-Cell, Anaplastic (1)  ·  Lymphoma, T-Cell, Cutaneous (1)  ·  Mycosis Fungoides (1)  ·  Subcutaneous panniculitis-like T-cell lymphoma (1)

Broader conditions

Hemic and Lymphatic Diseases (2)  ·  Immune System Diseases (2)  ·  Immunoproliferative Disorders (2)  ·  Lymphatic Diseases (2)  ·  Lymphoma (2)  ·  Lymphoma, Non-Hodgkin (2)  ·  Lymphoproliferative Disorders (2)  ·  Neoplasms (2)  ·  Neoplasms by Histologic Type (2)

Interventions

10-propargyl-10-deazaaminopterin (1)  ·  Azacitidine (1)  ·  Fluorodeoxyglucose F18 (1)  ·  MEDI-570 (1)  ·  Magnetic Resonance Spectroscopy (1)  ·  Specimen Handling (1)  ·  belinostat (1)

Sponsors

City of Hope Medical Center (1)  ·  National Cancer Institute (NCI) (1)

Countries

United States (2)  ·  Canada (1)

Top investigators

Christina Poh (1)  ·  Julio C Chavez (1)

Results publications

PMID 36826995

NIH funding

P30CA033572 (1), UM1CA186644 (1)